Aclaris Therapeutics Inc.
Exchange: IEX Type: Common Stock
Price at Close
Change:
Volume:
×
Buy Stock
Remote Buying of Aclaris Therapeutics Inc. through IEX is under development on ETFS.com.
Notify Me when it is ready×
Sell Stock
Remote Selling of Aclaris Therapeutics Inc. through IEX is under development on ETFS.com.
Notify Me when it is ready
Key Statistics
- Open
- Previous Close
- Bid
- Ask
- Day Range -
- 52 Week Range -
- Volume
- Avg. Volume
- Volume to USD
- Market Cap
- Beta
- PE Ratio
- Latest EPS
- EPS TTM
- Dividend
- Dividend Yield
- Ex-Dividend Date
- Revenue TTM
- Revenue per Share
- Revenue per Employee
- Profit Margin
- Gross Profit TTM
- Total Cash TTM
- Total Debt TTM
Share Distribution
- Shares Outstanding
- Float
- Short Interest
- Short Ratio
- Insider Ownership
- Institution Ownership
Latest Headlines
How Joe Biden's healthcare plan compares to 'Medicare For All" plans via MSNBC
Cara Therapeutics And Korsuva: An Analgesic Opioid Peptide Targeting Cholestasis Pruritus via Seeking Alpha
Akero Therapeutics started at overweight with $28 stock price target at J.P. Morgan via MarketWatch
Aclaris Therapeutics Inc. Performance
Active Alerts for IEX:ACRS
You don't have any alerts set for IEX:ACRS.
About Aclaris Therapeutics Inc.
Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology.
Real-time ACRS to USD Trade Analysis on IEX
Market Status Closed
Analysis is available when the exchange & market are open.